FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743103162> ?p ?o ?g. }

• W2743103162 endingPage "741" @default.
• W2743103162 startingPage "734" @default.
• W2743103162 abstract "The efficacy and safety of asunaprevir + daclatasvir combination therapy for treatment of hepatitis C virus (HCV) in compensated cirrhotic patients was not fully evaluated in real-world. Outcomes were assessed in cirrhotic patients with sustained viral response (SVR). A total of 145 patients without resistance-associated substitutions (RASs) at L31 and Y93 in the nonstructural protein 5A of HCV genotype 1b, consisting of 49 hepatic cirrhotic and 96 non-cirrhotic patients, were enrolled to the therapy. The patients were treated with 100 mg asunaprevir twice daily plus 60 mg daclatasvir once daily for 24 weeks. The primary endpoint was SVR 24 weeks after completing treatment. In addition, we evaluated the improvement of liver function and development of HCC for 1 year from the end of treatment (EOT). The SVR24 rate was 96% (47/49) in the cirrhotic group and 96% (91/95) in the non-cirrhotic group (p = 0.69). During treatment, grade III/IV adverse events occurred more frequently in cir-rhotic patients (10/49; 20.4%) than in non-cirrhotic patients (10/96; 10.4%) (p = 0.099). After EOT, alanine aminotransferase and AFP levels were significantly decreased in cirrhotic patients with SVR. In addition, serum levels of albumin and platelet counts were significantly increased. On the other hand, the rates of HCC recurrence (43%) and development (7.4%) were higher in cirrhotic patients than in the non-cirrhotic patients (12.5% and 1.1%, respectively). RAS-oriented asunaprevir/daclatasvir therapy has a strong anti-HCV effect in patients with HCV genotype 1b. However, careful management is necessary in patients with cirrhosis." @default.
• W2743103162 created "2017-08-17" @default.
• W2743103162 creator A5003256422 @default.
• W2743103162 creator A5005826951 @default.
• W2743103162 creator A5018409403 @default.
• W2743103162 creator A5019783291 @default.
• W2743103162 creator A5024647870 @default.
• W2743103162 creator A5047937463 @default.
• W2743103162 creator A5049754289 @default.
• W2743103162 creator A5054249340 @default.
• W2743103162 creator A5067647579 @default.
• W2743103162 creator A5081066622 @default.
• W2743103162 creator A5090334203 @default.
• W2743103162 creator A5091645918 @default.
• W2743103162 date "2017-09-01" @default.
• W2743103162 modified "2023-09-26" @default.
• W2743103162 title "Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination" @default.
• W2743103162 cites W1551301313 @default.
• W2743103162 cites W1979174109 @default.
• W2743103162 cites W1987584200 @default.
• W2743103162 cites W2026614040 @default.
• W2743103162 cites W2030439961 @default.
• W2743103162 cites W2078463533 @default.
• W2743103162 cites W2099304129 @default.
• W2743103162 cites W2101598010 @default.
• W2743103162 cites W2142660384 @default.
• W2743103162 cites W2144792064 @default.
• W2743103162 cites W2162078710 @default.
• W2743103162 cites W2179458651 @default.
• W2743103162 cites W2220460165 @default.
• W2743103162 cites W2289307263 @default.
• W2743103162 cites W2335913920 @default.
• W2743103162 cites W2399411325 @default.
• W2743103162 cites W2406748516 @default.
• W2743103162 cites W2467713285 @default.
• W2743103162 cites W2514130042 @default.
• W2743103162 cites W4245344375 @default.
• W2743103162 doi "https://doi.org/10.5604/01.3001.0010.2732" @default.
• W2743103162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28809743" @default.
• W2743103162 hasPublicationYear "2017" @default.
• W2743103162 type Work @default.
• W2743103162 sameAs 2743103162 @default.
• W2743103162 citedByCount "8" @default.
• W2743103162 countsByYear W27431031622018 @default.
• W2743103162 countsByYear W27431031622019 @default.
• W2743103162 countsByYear W27431031622020 @default.
• W2743103162 crossrefType "journal-article" @default.
• W2743103162 hasAuthorship W2743103162A5003256422 @default.
• W2743103162 hasAuthorship W2743103162A5005826951 @default.
• W2743103162 hasAuthorship W2743103162A5018409403 @default.
• W2743103162 hasAuthorship W2743103162A5019783291 @default.
• W2743103162 hasAuthorship W2743103162A5024647870 @default.
• W2743103162 hasAuthorship W2743103162A5047937463 @default.
• W2743103162 hasAuthorship W2743103162A5049754289 @default.
• W2743103162 hasAuthorship W2743103162A5054249340 @default.
• W2743103162 hasAuthorship W2743103162A5067647579 @default.
• W2743103162 hasAuthorship W2743103162A5081066622 @default.
• W2743103162 hasAuthorship W2743103162A5090334203 @default.
• W2743103162 hasAuthorship W2743103162A5091645918 @default.
• W2743103162 hasBestOaLocation W27431031621 @default.
• W2743103162 hasConcept C126322002 @default.
• W2743103162 hasConcept C159047783 @default.
• W2743103162 hasConcept C197934379 @default.
• W2743103162 hasConcept C203092338 @default.
• W2743103162 hasConcept C2522874641 @default.
• W2743103162 hasConcept C2776125364 @default.
• W2743103162 hasConcept C2776408679 @default.
• W2743103162 hasConcept C2776979040 @default.
• W2743103162 hasConcept C2778606649 @default.
• W2743103162 hasConcept C2780040827 @default.
• W2743103162 hasConcept C2992208098 @default.
• W2743103162 hasConcept C535046627 @default.
• W2743103162 hasConcept C71924100 @default.
• W2743103162 hasConcept C90924648 @default.
• W2743103162 hasConceptScore W2743103162C126322002 @default.
• W2743103162 hasConceptScore W2743103162C159047783 @default.
• W2743103162 hasConceptScore W2743103162C197934379 @default.
• W2743103162 hasConceptScore W2743103162C203092338 @default.
• W2743103162 hasConceptScore W2743103162C2522874641 @default.
• W2743103162 hasConceptScore W2743103162C2776125364 @default.
• W2743103162 hasConceptScore W2743103162C2776408679 @default.
• W2743103162 hasConceptScore W2743103162C2776979040 @default.
• W2743103162 hasConceptScore W2743103162C2778606649 @default.
• W2743103162 hasConceptScore W2743103162C2780040827 @default.
• W2743103162 hasConceptScore W2743103162C2992208098 @default.
• W2743103162 hasConceptScore W2743103162C535046627 @default.
• W2743103162 hasConceptScore W2743103162C71924100 @default.
• W2743103162 hasConceptScore W2743103162C90924648 @default.
• W2743103162 hasIssue "5" @default.
• W2743103162 hasLocation W27431031621 @default.
• W2743103162 hasLocation W27431031622 @default.
• W2743103162 hasOpenAccess W2743103162 @default.
• W2743103162 hasPrimaryLocation W27431031621 @default.
• W2743103162 hasRelatedWork W2124094352 @default.
• W2743103162 hasRelatedWork W2179458651 @default.
• W2743103162 hasRelatedWork W2363688200 @default.
• W2743103162 hasRelatedWork W2393595327 @default.
• W2743103162 hasRelatedWork W2597706416 @default.

• next